A Study of Belantamab Mafodotin in Combination With Nirogacestat and Pomalidomide in People With Multiple Myeloma That Has Not Responded to Treatment or Has Come Back After Treatment
Clinical trial NCT05556798 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05556798
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-04
- Primary completion
- 2027-10-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.